Whole Slide Imaging Market Scope
Whole slide imaging (WSI), which refers to the scanning of typical glass slides so as to supply digital slides, is that the most up-to-date imaging modality being utilized by pathology departments worldwide. WSI continues to realize traction among pathologists for diagnostic, instructional, and analysis functions.
The Whole Slide Imaging market study is segmented, by Application (Telepathology, Cytopathology, Immunohistochemistry and Hematopathology) and major geographies with country level break-up.
The global market for Whole Slide Imaging is fragmented by key players owing to evolving pharmaceutical and Medicare industry. The rising players and start-ups should invest in R&D and more employable and affordable machinery and system components in order to carry out the drug research and treatments.
Philips (Netherlands), Siemens (Germany), Molecular Machines & Industries (Germany), Agfa-Gevaert N.V. (Belgium), CardiArc Ltd. (United States), Digirad Corporation (United States), Gamma Medica Inc. (United States), GE Healthcare (United States), Hologic Inc. (United States) and Leica Microsystems GmbH (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Nikon Corporation (Japan), Visiopharm (Denmark), 3Dhistech (Hungary), Hamamatsu Photonics KK (Japan) and Indica Labs (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Whole Slide Imaging market by Type, Application and Region.
On the basis of geography, the market of Whole Slide Imaging has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In 2019, MMI officially launched an imaging solution at the Digital Pathology congress. The MMI CellScan is a new stand-alone system for Whole Slide Imaging which can scan full-resolution digital slides in any magnification and fluorescence.
Market Trend
- Focus of Biotech Companies towards using WSI for Early and Late-Stage Drug Development
Market Drivers
- Rise in Drug Discovery for Mutating Diseases and Increasing Medical Attention
- Rise in Popularity of Virtual Imaging over Physical Slide Imaging
Opportunities
- Sudden Spike in Healthcare Industry and Pharmaceuticals for Increasing Cancer Prone People
- Rapid Growth in Digital Pathology, which Will Help in Advanced Ways of Analysis and Fast Track Work
Restraints
- Initial Economic Investment for Employment of The Scanner and The Complete WSI System
Challenges
- Skilled Manpower Needed for Operation of Systems
- Preference of Using Conventional Methods for Slide Imaging
Key Target Audience
Whole Slide Imaging System Manufacturer, Provider/Distributor, Healthcare Firms, Laboratories and Others
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase